133 related articles for article (PubMed ID: 29572500)
21. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
22. Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia.
Di Bona E; Avvisati G; Castaman G; Luce Vegna M; De Sanctis V; Rodeghiero F; Mandelli F
Br J Haematol; 2000 Mar; 108(4):689-95. PubMed ID: 10792270
[TBL] [Abstract][Full Text] [Related]
23. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
Mantha S; Goldman DA; Devlin SM; Lee JW; Zannino D; Collins M; Douer D; Iland HJ; Litzow MR; Stein EM; Appelbaum FR; Larson RA; Stone R; Powell BL; Geyer S; Laumann K; Rowe JM; Erba H; Coutre S; Othus M; Park JH; Wiernik PH; Tallman MS
Blood; 2017 Mar; 129(13):1763-1767. PubMed ID: 28082441
[TBL] [Abstract][Full Text] [Related]
24. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience.
Akcay OF; Yeter HH; Buyukasik Y
Rom J Intern Med; 2020 Sep; 58(3):138-145. PubMed ID: 32452194
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts.
Ono T; Takeshita A; Kishimoto Y; Kiyoi H; Okada M; Yamauchi T; Emi N; Horikawa K; Matsuda M; Shinagawa K; Monma F; Ohtake S; Nakaseko C; Takahashi M; Kimura Y; Iwanaga M; Asou N; Naoe T;
Cancer Sci; 2014 Jan; 105(1):97-104. PubMed ID: 24206578
[TBL] [Abstract][Full Text] [Related]
26. Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy.
Gernez Y; Tirouvanziam R; Yu G; Ghosn EE; Reshamwala N; Nguyen T; Tsai M; Galli SJ; Herzenberg LA; Herzenberg LA; Nadeau KC
Int Arch Allergy Immunol; 2011; 154(4):318-27. PubMed ID: 20975283
[TBL] [Abstract][Full Text] [Related]
27. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
Tallman MS; Abutalib SA; Altman JK
Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia.
Rasekh EO; Elsayed GM; Madney Y; El Gammal MM
Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):156-167. PubMed ID: 32033928
[TBL] [Abstract][Full Text] [Related]
29. Translocations t(15;17) and t(9;14)(q34;q22) in a case of acute promyelocytic leukemia with increased number of basophils.
Gotoh H; Murakami S; Oku N; Itoh K; Takeda N; Fujita N; Shimazaki C; Nishio A; Haruyama H; Nakagawa M
Cancer Genet Cytogenet; 1988 Nov; 36(1):103-7. PubMed ID: 3203292
[TBL] [Abstract][Full Text] [Related]
30. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Cervera J; Montesinos P; Hernández-Rivas JM; Calasanz MJ; Aventín A; Ferro MT; Luño E; Sánchez J; Vellenga E; Rayón C; Milone G; de la Serna J; Rivas C; González JD; Tormo M; Amutio E; González M; Brunet S; Lowenberg B; Sanz MA
Haematologica; 2010 Mar; 95(3):424-31. PubMed ID: 19903674
[TBL] [Abstract][Full Text] [Related]
31. Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia.
Pei Y; Shi M; Song J; Niu X; Wei S; Dou L; Xiao M; Li D; Xu F; Bai Y; Sun K
Cancer Manag Res; 2021; 13():4135-4146. PubMed ID: 34045900
[TBL] [Abstract][Full Text] [Related]
32. Increased level of basophil CD203c expression predicts severe chronic urticaria.
Ye YM; Yang EM; Yoo HS; Shin YS; Kim SH; Park HS
J Korean Med Sci; 2014 Jan; 29(1):43-7. PubMed ID: 24431904
[TBL] [Abstract][Full Text] [Related]
33. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
[TBL] [Abstract][Full Text] [Related]
34. CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition.
Wang C; Wang Y; Zuo N; Fang S; Shi J
Blood Adv; 2022 Aug; 6(15):4617-4633. PubMed ID: 35511736
[TBL] [Abstract][Full Text] [Related]
35. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
[TBL] [Abstract][Full Text] [Related]
36. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
[TBL] [Abstract][Full Text] [Related]
37. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
Breccia M; Lo Coco F
Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
[TBL] [Abstract][Full Text] [Related]
38. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.
Wen J; Xu F; Zhou Q; Shi L; Liu Y; Yue J; Zhang Y; Liang X
BMC Cancer; 2023 Jan; 23(1):27. PubMed ID: 36611025
[TBL] [Abstract][Full Text] [Related]
39. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
[TBL] [Abstract][Full Text] [Related]
40. Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia.
Song YH; Peng P; Qiao C; Zhang R; Li JY; Lu H
Onco Targets Ther; 2017; 10():4917-4924. PubMed ID: 29062237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
